{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:31:07Z","timestamp":1791322267106,"version":"4.3.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,9,11]],"date-time":"2007-09-11T00:00:00Z","timestamp":1189468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s12032-007-9004-4","type":"journal-article","created":{"date-parts":[[2007,9,10]],"date-time":"2007-09-10T11:47:32Z","timestamp":1189424852000},"page":"137-147","source":"Crossref","is-referenced-by-count":39,"title":["Anti-tumor cytotoxicity of \u03b3\u03b4 T cells expanded from peripheral blood cells of patients with myeloma and lymphoma"],"prefix":"10.1007","volume":"25","author":[{"given":"Anri","family":"Saitoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miwako","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Tochiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Toba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifusa","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohji","family":"Shinada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masuhiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,11]]},"reference":[{"key":"9004_CR1","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nri797","volume":"2","author":"SR Carding","year":"2002","unstructured":"Carding SR, Egan PJ. \u03b3\u03b4 T cells: functional plasticity and heterogeneity. Nat Rev Immunol 2002;2:336\u201345.","journal-title":"Nat Rev Immunol"},{"key":"9004_CR2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/375155a0","volume":"375","author":"Y Tanaka","year":"1995","unstructured":"Tanaka Y, et al. Natural and synthetic non-peptide antigens recognized by human \u03b3\u03b4 T cells. Nature 1995;375:155\u20138.","journal-title":"Nature"},{"key":"9004_CR3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1074-7613(00)80081-3","volume":"11","author":"JF Bukowski","year":"1999","unstructured":"Bukowski JF, Morita CT, Brenner MB. Human \u03b3\u03b4 T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity. Immunity 1999;11:57\u201365.","journal-title":"Immunity"},{"key":"9004_CR4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJM199903043400914","volume":"340","author":"V Kunzmann","year":"1999","unstructured":"Kunzmann V, Bauer E, Wilhelm M. \u03b3\u03b4 T-cell stimulation by pamidronate. N Engl J Med 1999;340:737\u20138.","journal-title":"N Engl J Med"},{"key":"9004_CR5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1471-4906(03)00032-2","volume":"24","author":"ZW Chen","year":"2003","unstructured":"Chen ZW, Letvin NL. Adaptive immune response of \u03b3(\u03b4( T cells: a new paradigm. Trends Immunol 2003;24:213\u20139.","journal-title":"Trends Immunol"},{"key":"9004_CR6","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V96.2.384","volume":"96","author":"V Kunzmann","year":"2000","unstructured":"Kunzmann V, et al. Stimulation of \u03b3\u03b4 T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 2000;96:384\u201392.","journal-title":"Blood"},{"key":"9004_CR7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1084\/jem.20021500","volume":"197","author":"HJ Gober","year":"2003","unstructured":"Gober HJ, et al. Human T cell receptor \u03b3\u03b4 cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med 2003;197:163\u20138.","journal-title":"J Exp Med"},{"key":"9004_CR8","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0022-2275(20)41954-6","volume":"32","author":"HJ Harwood Jr","year":"1991","unstructured":"Harwood HJ Jr, Alvarez IM, Noyes WD, Stacpoole PW. In vivo regulation of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase: increased enzyme protein concentration and catalytic efficiency in human leukemia and lymphoma. J Lipid Res 1991;32:1237\u201352.","journal-title":"J Lipid Res"},{"key":"9004_CR9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1006\/bbrc.1999.0945","volume":"260","author":"R Asslan","year":"1999","unstructured":"Asslan R, et al. Epidermal growth factor stimulates 3-hydroxy-3-methylglutaryl-coenzyme A reductase expression via the ErbB-2 pathway in human breast adenocarcinoma cells. Biochem Biophys Res Commun 1999;260:699\u2013706.","journal-title":"Biochem Biophys Res Commun"},{"key":"9004_CR10","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1158\/0008-5472.CAN-05-0731","volume":"65","author":"S Girlanda","year":"2005","unstructured":"Girlanda S, et al. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells co-stimulates pamidronate-activated \u03b3\u03b4 lymphocytes. Cancer Res 2005;65:7502\u20138.","journal-title":"Cancer Res"},{"key":"9004_CR11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4049\/jimmunol.177.2.877","volume":"177","author":"Y Kato","year":"2006","unstructured":"Kato Y, Tanaka Y, Hayashi M, Okawa K, Minato N. Involvement of CD166 in the activation of human \u03b3\u03b4 T cells by tumor cells sensitized with nonpeptide antigens. J Immunol 2006;177:877\u201384.","journal-title":"J Immunol"},{"key":"9004_CR12","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.4049\/jimmunol.173.6.3660","volume":"173","author":"JE Dalton","year":"2004","unstructured":"Dalton JE, Howell G, Pearson J, Scott P, Carding SR. Fas-Fas ligand interactions are essential for the binding to and killing of activated macrophages by gamma delta T cells. J Immunol 2004;173:3660\u20137.","journal-title":"J Immunol"},{"key":"9004_CR13","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4049\/jimmunol.174.3.1338","volume":"174","author":"E Viey","year":"2005","unstructured":"Viey E, et al. Phosphostim-activated \u03b3\u03b4 T cells kill autologous metastatic renal cell carcinoma. J Immunol 2005;174:1338\u201347.","journal-title":"J Immunol"},{"key":"9004_CR14","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nri797","volume":"2","author":"SR Carding","year":"2002","unstructured":"Carding SR, Egan PJ. \u03b3\u03b4 T cells: functional plasticity and heterogeneity. Nat Rev Immunol 2002;2:336\u201345.","journal-title":"Nat Rev Immunol"},{"key":"9004_CR15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/clim.2002.5218","volume":"103","author":"J Ismaili","year":"2002","unstructured":"Ismaili J, Olislagers V, Poupot R, Fournie JJ, Goldman M. Human \u03b3\u03b4 T cells induce dendritic cell maturation. Clin Immunol 2002;103:296\u2013302.","journal-title":"Clin Immunol"},{"key":"9004_CR16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/14653240600620200","volume":"8","author":"N Watanabe","year":"2006","unstructured":"Watanabe N, et al. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of \u03b3\u03b4 T cells expanded from peripheral blood cells by stimulation with zoledronate. Cytotherapy 2006;8:118\u201329.","journal-title":"Cytotherapy"},{"key":"9004_CR17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1385\/MO:20:4:335","volume":"20","author":"M Takahashi","year":"2003","unstructured":"Takahashi M, Narita M, Ayres F, Satoh N, Abe T, Yanao T, Furukawa T, Toba K, Hirohashi T, Aizawa Y. Cytoplasmic expression of EGFP in DC transfected with in vitro transcribed mRNA or cellular total RNA extracted from EGFP expressing leukemia cells. Med Oncol 2003;20:335\u201348.","journal-title":"Med Oncol"},{"key":"9004_CR18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/14653240310001064","volume":"5","author":"Y Osman","year":"2003","unstructured":"Osman Y, et al. Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA. Cytotherapy 2003;5:161\u20138.","journal-title":"Cytotherapy"},{"key":"9004_CR19","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1182\/blood-2003-06-2070","volume":"103","author":"I Jedema","year":"2004","unstructured":"Jedema I, van der Werff NM, Barge RM, Willemze R, Falkenburg JH. New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood 2004;103:2677\u201382.","journal-title":"Blood"},{"key":"9004_CR20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V96.2.384","volume":"96","author":"V Kunzmann","year":"2000","unstructured":"Kunzmann V, et al. Stimulation of \u03b3\u03b4 T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 2000;96:384\u201392.","journal-title":"Blood"},{"key":"9004_CR21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/BF03401961","volume":"7","author":"H Sicard","year":"2001","unstructured":"Sicard H, Al Saati T, Delsol G, Fournie JJ. Synthetic phosphoantigens enhance human \u03b3\u03b4 T lymphocytes killing of non-Hodgkin\u2019s B lymphoma. Mol Med 2001;7:711\u201322.","journal-title":"Mol Med"},{"key":"9004_CR22","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1182\/blood.V98.5.1616","volume":"98","author":"H Das","year":"2001","unstructured":"Das H, Wang L, Kamath A, Bukowski JF. \u03b3\u03b4 T-cell receptor-mediated recognition of aminobisphosphonates. Blood 2001;98:1616\u20138.","journal-title":"Blood"},{"key":"9004_CR23","doi-asserted-by":"crossref","first-page":"6767","DOI":"10.4049\/jimmunol.173.11.6767","volume":"173","author":"D Kabelitz","year":"2004","unstructured":"Kabelitz D, Wesch D, Pitters E, Zoller M. Characterization of tumor reactivity of human V \u03b3\u03b4 T cells in vitro and in SCID mice in vivo. J Immunol 2004;173:6767\u201376.","journal-title":"J Immunol"},{"key":"9004_CR24","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.4049\/jimmunol.167.9.5092","volume":"167","author":"Y Kato","year":"2001","unstructured":"Kato Y, Tanaka Y, Miyagawa F, Yamashita S, Minato N. Targeting of tumor cells for human \u03b3\u03b4 T cells by nonpeptide antigens. J Immunol 2001;167:5092\u20138.","journal-title":"J Immunol"},{"key":"9004_CR25","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1182\/blood.V97.9.2917","volume":"97","author":"K Schilbach","year":"2001","unstructured":"Schilbach K, Geiselhart A, Handgretinger R. Induction of proliferation and augmented cytotoxicity of \u03b3\u03b4 T lymphocytes by bisphosphonate clodronate. Blood 2001;97:2917\u20138.","journal-title":"Blood"},{"key":"9004_CR26","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbrc.2004.11.075","volume":"328","author":"JF Bukowski","year":"2005","unstructured":"Bukowski JF, Dascher CC, Das H. Alternative bisphosphonate targets and mechanisms of action. Biochem Biophys Res Commun 2005;328:746\u201350.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-007-9004-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-007-9004-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-007-9004-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T02:06:13Z","timestamp":1629684373000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-007-9004-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,11]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["9004"],"URL":"https:\/\/doi.org\/10.1007\/s12032-007-9004-4","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,11]]}}}